Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin Periocular Injection for Retinoblastoma
NCT02137928Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2006
- Primary completion
- Dec 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin in retinoblastoma (Rb), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
carboplatin
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT02137928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137928.